Electromed, Inc. Overview
Pro stress-test →Electromed is a profitable and growing medical device company that develops, manufactures, markets and sells innovative High Frequency Chest Wall Oscillation (HFCWO) airway clearance products, primarily for use in the home setting. The company serves patients with compromised pulmonary function from conditions including cystic fibrosis, bronchiectasis, and neuromuscular disorders.
Strategic Profile
Pro stress-test →The company's strategic focus on product innovation, sales force expansion, operational efficiency, and market penetration has enabled it to maintain a strong competitive position and deliver steady growth. The company reported net revenues of $54.72 million for fiscal 2024 with strong momentum continuing into 2025, demonstrating 18-19% year-over-year growth.
Competitive Landscape
Pro stress-test →Electromed operates in a specialized niche within the respiratory medical device market with limited direct competitors focused specifically on HFCWO therapy. The company competes against broader respiratory care providers and alternative airway clearance methods, but maintains a strong market position through its patented SmartVest technology and proven clinical efficacy.
Industry Context
Electromed, Inc. operates in Medical Devices - Respiratory/Airway Clearance.
Key facts
Founded: 1992 · Headquarters: New Prague, Minnesota, US · Revenue: $54.7M (FY2024)